Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
taVNS in Dry Eye Disease
NCT06696625Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Jul 2021
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Ocular Surface Disease Index at 6 months. Started Jul 2021; status: recruiting.
Beyond the preview
Go deeper on NCT06696625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06696625.